Scrimmage

Scrimmage delivers a specialized platform that empowers organizations to enhance their workforce training through immersive simulations, focusing on skill development and performance optimization in real-world scenarios. Scrimmage, founded in 2010 and headquartered in Minneapolis, US, operates as a subsidiary of ACTO Technologies Inc. , which specializes in AI-driven solutions for the life sciences industry. The company was acquired by ACTO in September 2020, with financial terms undisclosed.

Derek Lundsten serves as CEO, leading the company with a focus on innovation and engagement. Scrimmage offers an advanced platform leveraging AI for immersive simulation training. Their solutions enhance the competence of field professionals, particularly in the life sciences sector, by providing tools for role-play and realistic interaction scenarios. This approach is designed to improve engagement between field representatives and healthcare providers (HCPs), ensuring effective communication and training retention.

Scrimmage generates revenue primarily through subscription-based agreements, allowing clients access to their robust training platform. The company forms structured partnerships with clients, primarily in the life sciences sector, to implement their training solutions effectively. Revenue comes from various activities, including product demonstrations and ongoing support services, with typical contracts structured for multiple years. With the recent acquisition in September 2020, Scrimmage aims to expand its product offerings and enhance its market reach.

The company plans to introduce new training modules specifically tailored for the pharmaceutical industry, focusing on engaging new clients across North America and Europe by 2023. The recent funding will support these initiatives, facilitating the development of advanced features and broader market accessibility.